Literature DB >> 2205107

Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid.

M W Schwartz1, A Sipols, S E Kahn, D F Lattemann, G J Taborsky, R N Bergman, S C Woods, D Porte.   

Abstract

To characterize the relationship between insulin levels in plasma and those in cerebrospinal fluid (CSF), we studied the kinetics of both the uptake of insulin into CSF from plasma and the turnover of insulin within the CSF compartment. Sustained physiological levels of euglycemic hyperinsulinemia (plasma insulin approximately 500 pM) did not alter CSF insulin levels within the 1st h, but by 90 min a significant increase was observed (P less than 0.01). During graded hyperinsulinemic clamps (mean plasma insulin approximately 500-15,000 pM), CSF insulin rose in a dose-dependent fashion. This rise was characterized by an initial delay followed by a continuous increase for the next 150 min. We also found that after brief, high-dose intravenous insulin infusions, the t1/2 of CSF insulin was 143 +/- 7 min (means +/- SE; n = 4), similar to that of CSF turnover by bulk flow. To test the specificity of CSF insulin uptake from plasma, we compared this uptake during intravenous insulin infusions with that of proinsulin, a peptide with reduced affinity for the insulin receptor. We observed a significantly lower increment of CSF proinsulin levels over 180 min (13.6 +/- 1.6 pM; means +/- SE; n = 4) compared with that of insulin (22.4 +/- 0.6 pM; n = 4; P less than 0.01), despite plasma proinsulin levels higher than insulin (1,890 +/- 287 vs. 1,283 +/- 192 pM; P less than 0.001). When corrected for the difference in plasma levels, the uptake of insulin was fivefold greater than that of proinsulin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205107     DOI: 10.1152/ajpendo.1990.259.3.E378

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  48 in total

Review 1.  Endothelial vesicles in the blood-brain barrier: are they related to permeability?

Authors:  P A Stewart
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans.

Authors:  Colin N Young; Shekhar H Deo; Kunal Chaudhary; John P Thyfault; Paul J Fadel
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

3.  Aggregation of vascular risk factors and risk of incident Alzheimer disease.

Authors:  J A Luchsinger; C Reitz; L S Honig; M X Tang; Steven Shea; R Mayeux
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 4.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

Review 5.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

6.  Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport.

Authors:  M W Schwartz; R N Bergman; S E Kahn; G J Taborsky; L D Fisher; A J Sipols; S C Woods; G M Steil; D Porte
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

7.  Human insulin and hypoglycaemia: burning issue or hot air?

Authors:  G Williams; A W Patrick
Journal:  BMJ       Date:  1992-08-08

Review 8.  Hypothalamic control of energy and glucose metabolism.

Authors:  Stephanie Sisley; Darleen Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

9.  A summary risk score for the prediction of Alzheimer disease in elderly persons.

Authors:  Christiane Reitz; Ming-Xin Tang; Nicole Schupf; Jennifer J Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2010-07

10.  Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain.

Authors:  G D Baura; D M Foster; D Porte; S E Kahn; R N Bergman; C Cobelli; M W Schwartz
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.